Erratum: Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis
Saved in:
| Main Author: | Frontiers Production Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1605861/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
by: Shengxue Luo, et al.
Published: (2021-01-01) -
Inactivated mycobacterium paragordonae delivered via microneedle patches as a novel tuberculosis booster vaccine
by: Moonsu Lee, et al.
Published: (2025-12-01) -
Design of a multi-epitope vaccine against drug-resistant mycobacterium tuberculosis and mycobacterium bovis using reverse vaccinology
by: Eva Akurut, et al.
Published: (2025-07-01) -
Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever
by: O. Popova, et al.
Published: (2025-01-01) -
Vaccination with a low dose of BCG or BCG∆BCG1419c protects against short-term Mycobacterium tuberculosis HN878 infection in male CB6F1 mice
by: Jorge Barrios-Payán, et al.
Published: (2025-07-01)